Intraoral administration of botulinum toxin for trigeminal neuropathic pain

被引:20
作者
Babiloni, Alberto Herrero [1 ,3 ]
Kapos, Flavia P. [3 ]
Nixdorf, Donald R. [2 ,3 ,4 ]
机构
[1] Univ Minnesota, 6-320 Moos Tower 515 Delaware St SE, Minneapolis, MN 55455 USA
[2] HealthPartners Inst Educ & Res, Bloomington, MN USA
[3] Univ Minnesota, Sch Dent, Div TMD & Orofacial Pain, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 2016年 / 121卷 / 06期
关键词
PHARMACOLOGICAL MANAGEMENT; DOUBLE-BLIND; NEURALGIA; GUIDELINES; INJECTIONS; LIDOCAINE;
D O I
10.1016/j.oooo.2016.03.013
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
This article presents 2 cases of different neuropathic trigeminal pain conditions treated with intraoral botulinum toxin injections. There is a growing body of evidence to support the use of this substance when administered subcutaneously in the treatment of neuropathic pain, such as in extraoral injections for trigeminal neuralgia. However, reports of intraoral submucosal administration are still lacking. In the 2 cases presented here, neuropathic pain was refractory to treatment with an important intraoral peripheral component, so onabotulinum toxin A was introduced as an adjuvant therapy. The technique, doses, and dilution are discussed. The patients reported significant reductions in pain frequency and intensity, with minimal side effects of temporary mucosal dryness and smile droopiness. The analgesic benefits of botulinum toxin may be utilized to address intraoral neuropathic pain. Further studies are needed to confirm safety and effectiveness in larger samples.
引用
收藏
页码:E148 / E153
页数:6
相关论文
共 37 条
[1]   Terminology for Preparations of Botulinum Neurotoxins What a Difference a Name Makes [J].
Albanese, Alberto .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (01) :89-90
[2]   Injections of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia [J].
Allam, N ;
Brasil-Neto, JP ;
Brown, G ;
Tomaz, C .
CLINICAL JOURNAL OF PAIN, 2005, 21 (02) :182-184
[3]   Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A [J].
Aoki, KR .
NEUROTOXICOLOGY, 2005, 26 (05) :785-793
[4]   EFNS guidelines on pharmacological treatment of neuropathic pain [J].
Attal, N. ;
Cruccu, G. ;
Haanpaa, M. ;
Hansson, P. ;
Jensen, T. S. ;
Nurmikko, T. ;
Sampaio, C. ;
Sindrup, S. ;
Wiffen, P. .
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (11) :1153-1169
[5]   Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report [J].
Bohluli, Behnam ;
Motamedi, Mohammad Hosein Kalantar ;
Bagheri, Shahrokh C. ;
Bayat, Mohammad ;
Lassemi, Eshagh ;
Navi, Fina ;
Moharamnejad, Nima .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2011, 111 (01) :47-50
[6]   The use of botulinum toxin for the treatment of chronic facial pain [J].
Borodic, GE ;
Acquadro, MA .
JOURNAL OF PAIN, 2002, 3 (01) :21-27
[7]   Painful tic convulsif and botulinum toxin [J].
Bosca-Asco, M. E. ;
Burguera-Hernandez, J. A. ;
Roig-Morata, S. ;
Martinez-Torres, I. .
REVISTA DE NEUROLOGIA, 2006, 42 (12) :729-732
[8]   Sympathetic Block with Botulinum Toxin to Treat Complex Regional Pain Syndrome [J].
Carroll, Ian ;
Clark, J. David ;
Mackey, Sean .
ANNALS OF NEUROLOGY, 2009, 65 (03) :348-351
[9]   Bilateral hemifacial spasm and trigeminal neuralgia: A unique form of painful tic convulsif [J].
Carvalho Felicio, Andre ;
De Oliveira Godeiro, Clecio, Jr. ;
Borges, Vanderci ;
Maria de Azevedo Silva, Sonia ;
Ferraz, Henrique Ballalai .
MOVEMENT DISORDERS, 2007, 22 (02) :285-286
[10]   Pharmacologic management of neuropathic pain: Evidence-based recommendations [J].
Dworkin, Robert H. ;
O'Connor, Alec B. ;
Backonja, Miroslav ;
Farrar, John T. ;
Finnerup, Nanna B. ;
Jensen, Troels S. ;
Kalso, Eija A. ;
Loeser, John D. ;
Miaskowski, Christine ;
Nurmikko, Turo J. ;
Portenoy, Russell K. ;
Rice, Andrew S. C. ;
Stacey, Brett R. ;
Treede, Rolf-Detlef ;
Turk, Dennis C. ;
Wallace, Mark S. .
PAIN, 2007, 132 (03) :237-251